Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 9Sarcoma 6Genitourinary 6Gastrointestinal 5Thoracic 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Head & Neck 2Dermatologic 2Other solid neoplasm 1NET 1Gynecologic 1Endocrine 1

Conditions

Multiple Myeloma 444Lymphoma 55Recurrence 44Neoplasms, Plasma Cell 35Immunoglobulin Light-chain Amyloidosis 34Hematologic Neoplasms 34Smoldering Multiple Myeloma 28Lymphoma, Non-Hodgkin 26Leukemia, Myeloid, Acute 22Leukemia, Lymphocytic, Chronic, B-Cell 21Neoplasms 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Hodgkin Disease 18Myelodysplastic Syndromes 17Monoclonal Gammopathy of Undetermined Significance 13Leukemia 12Waldenstrom Macroglobulinemia 11Lymphoma, Mantle-Cell 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Breast Neoplasms 11Prostatic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Paraproteinemias 9Ovarian Neoplasms 9Amyloidosis 9Lung Neoplasms 8Leukemia, Plasma Cell 8Primary Myelofibrosis 7Melanoma 7Lymphoma, Follicular 7

Interventions

fludarabine phosphate 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Plasma cell × 90 days × Clear all
NCT05092451 2026-05-06

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
80 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell

NCT01890486 2026-04-13

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Wake Forest University Health Sciences

Recruiting
2,000 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Germ Cell and Embryonal, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡